# Buprenorphine and Naloxone

NDC: 67296-2164
Generic name: Buprenorphine and Naloxone
Labeler / Manufacturer: Redpharm Drug
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: SUBLINGUAL
Marketing started: 20200413

FDA application: ANDA205601

## Active ingredients

- BUPRENORPHINE HYDROCHLORIDE: 8 mg/1
- NALOXONE HYDROCHLORIDE DIHYDRATE: 2 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67296-2164"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67296-2164
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=374530e2-3b2e-77d7-e063-6394a90a37c9